Subscribe

What are you looking for?

Main Menu

明報新聞網

石藥與阿斯利康簽戰略合作授權協議 將獲93億預付款

Future Wealths
Future Wealths
30 1 月, 2026
One Min Read
7 Views
0 Comments
石藥集團（1093）公布，與阿斯利康簽訂戰略研發合作與授權協議，以利用集團專有的緩釋給藥技術平台及多肽藥物AI發現平台，開發創新長效多肽藥物，石藥更將獲得12億美元（約93.6億港元）預付款。

原文: https://finance.mingpao.com/fin/instantf/20260130/1769737986514/%e7%9f%b3%e8%97%a5%e8%88%87%e9%98%bf%e6%96%af%e5%88%a9%e5%ba%b7%e7%b0%bd%e6%88%b0%e7%95%a5%e5%90%88%e4%bd%9c%e6%8e%88%e6%ac%8a%e5%8d%94%e8%ad%b0-%e5%b0%87%e7%8d%b293%e5%84%84%e9%a0%90%e4%bb%98%e6%ac%be

Last Update: 30 1 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept